Brief: Janone Advances Toward Initiation Of Phase 2B Peripheral Artery Disease Trial For Lead Product Candidate JAN101
08/06/2021 15:08
June 8 (Reuters) - Janone Inc JAN.O :
* JANONE ADVANCES TOWARD INITIATION OF PHASE 2B PERIPHERAL
ARTERY
DISEASE (PAD) TRIAL FOR LEAD PRODUCT CANDIDATE JAN101
Source text for Eikon: urn:newsml:reuters.com:*:nPn5YspqMa
Further company coverage: JAN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AI Financial
See all newsBrief: ALT5 Sigma Corporation Restores Compliance With Nasdaq Periodic Filing Requirements
Brief: Alt5 Sigma Expects To File Its Quarterly Report On Form 10-Q
Media: Trump-linked crypto venture Alt5 Sigma retains auditor - FT
Brief: ALT5 Sigma Corporation Provides Corporate Update
American Bitcoin steadies after share lock-up expiry sparks near 40% plunge (updated)